Can you provide the average price target for COGNEX CORP stock?
29 analysts have analysed CGNX and the average price target is 65.94 USD. This implies a price increase of 31.77% is expected in the next year compared to the current price of 50.04.
NASDAQ:CGNX • US1924221039
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for COGNEX CORP (CGNX).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-16 | Barclays | Maintains | Overweight -> Overweight |
| 2026-03-09 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2026-02-17 | DA Davidson | Maintains | Neutral -> Neutral |
| 2026-02-17 | Goldman Sachs | Maintains | Buy -> Buy |
| 2026-02-17 | HSBC | Upgrade | Hold -> Buy |
| 2026-02-13 | Keybanc | Maintains | Overweight -> Overweight |
| 2026-02-13 | Barclays | Maintains | Overweight -> Overweight |
| 2026-02-12 | Needham | Maintains | Buy -> Buy |
| 2026-01-12 | Barclays | Maintains | Overweight -> Overweight |
| 2025-12-18 | Truist Securities | Maintains | Hold -> Hold |
| 2025-12-16 | Goldman Sachs | Upgrade | Sell -> Buy |
| 2025-12-03 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2025-11-03 | DA Davidson | Maintains | Neutral -> Neutral |
| 2025-10-31 | Needham | Maintains | Buy -> Buy |
| 2025-10-31 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-08 | Barclays | Initiate | Overweight |
| 2025-10-08 | Truist Securities | Maintains | Hold -> Hold |
| 2025-09-16 | Goldman Sachs | Maintains | Sell -> Sell |
| 2025-09-15 | JP Morgan | Initiate | Neutral |
| 2025-08-04 | DA Davidson | Maintains | Neutral -> Neutral |
| 2025-08-01 | UBS | Maintains | Buy -> Buy |
| 2025-08-01 | Keybanc | Upgrade | Sector Weight -> Overweight |
| 2025-07-31 | Needham | Maintains | Buy -> Buy |
| 2025-07-14 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-06-16 | DA Davidson | Maintains | Neutral -> Neutral |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 837.547M -16.75% | 914.515M 9.19% | 994.359M 8.73% | 1.093B 9.92% | 1.189B 8.78% | 1.324B 11.35% | 1.506B 13.75% | 1.092B -27.49% | |
| EBITDA YoY % growth | 144.582M -49.83% | 147.754M 2.19% | 193.359M 30.87% | 260.03M 34.48% | 313.94M 20.73% | 369.01M 17.54% | 428.3M 16.07% | N/A | |
| EBIT YoY % growth | 122.702M -54.32% | 115.065M -6.22% | 162.566M 41.28% | 232.73M 43.16% | 284.79M 22.37% | 336.98M 18.33% | 402.35M 19.40% | 487.56M 21.18% | |
| Operating Margin | 14.65% | 12.58% | 16.35% | 21.29% | 23.95% | 25.45% | 26.72% | 44.65% | |
| EPS YoY % growth | 0.72 -45.04% | 0.74 2.78% | 1.01 36.49% | 1.27 26.23% | 1.55 21.84% | 1.62 4.24% | 2.30 41.73% | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.25 59.11% | 0.32 27.59% | 0.35 6.76% | 0.29 6.43% | 0.26 3.17% | 0.35 10.33% | 0.41 15.81% | 0.36 26.01% |
| Revenue Q2Q % growth | 251.91M 16.61% | 276.17M 10.87% | 287.92M 3.98% | 266.99M 5.81% | 255.34M 1.36% | 292.65M 5.97% | 307.42M 6.77% | 295.52M 10.69% |
| EBITDA Q2Q % growth | 52.897M 55.46% | 65.078M 9.62% | 70.749M -12.90% | 57.5M -12.97% | 53.698M 1.51% | 74.792M 14.93% | 79.009M 11.68% | 66.83M 16.23% |
| EBIT Q2Q % growth | 45.508M 74.41% | 58.451M 34.58% | 67.818M 17.40% | 52.422M 48.61% | 45.125M -0.84% | 66.939M 14.52% | 76.449M 12.73% | 66.191M 26.27% |
All data in USD
29 analysts have analysed CGNX and the average price target is 65.94 USD. This implies a price increase of 31.77% is expected in the next year compared to the current price of 50.04.
COGNEX CORP (CGNX) will report earnings on 2026-04-28.
The consensus EPS estimate for the next earnings of COGNEX CORP (CGNX) is 0.25 USD and the consensus revenue estimate is 251.91M USD.
The consensus rating for COGNEX CORP (CGNX) is 77.2414 / 100 . This indicates that analysts generally have a positive outlook on the stock.